ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
268 hedge funds and large institutions have $5.5B invested in Array Biopharma Inc in 2019 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
35% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 75
14% more funds holding
Funds holding: 236 → 268 (+32)
Holders
268
Holding in Top 10
13
Calls
$89.5M
Puts
$20.4M
Top Buyers
| 1 | +$144M | |
| 2 | +$103M | |
| 3 | +$62M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$48.8M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$37.3M |
Top Sellers
| 1 | -$134M | |
| 2 | -$98.4M | |
| 3 | -$36M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$35.9M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$32.3M |